XML 14 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 27,740 $ 65,793
Short-term investments 85,358 9,260
Receivables    
Trade, less allowance for credit losses of $4,850 and $5,201 as of September 30, 2020 and December 31, 2019, respectively 19,063 20,650
Related parties, less allowance for credit losses of $2,312 as of September 30, 2020 and December 31, 2019 12 600
Other 285 4,978
Inventory 10,348 16,097
Prepaid expenses and other 8,310 6,444
Current assets held for sale 0 110,821
Total current assets 151,116 234,643
Property, plant and equipment, net 44,685 60,969
Intangible assets, net 65,018 68,346
Goodwill 54,237 63,754
Investments in affiliates 337 1,461
Right-of-use assets 19,296 25,228
Other assets 1,497 1,362
Total assets 336,186 455,763
Current liabilities    
Accounts payable 4,233 5,917
Accrued compensation and benefits 7,567 14,091
Other accrued liabilities 9,355 12,049
Deferred revenue, including $0 and $877 from related parties as of September 30, 2020 and December 31, 2019, respectively 4,144 5,697
Lines of credit 0 1,922
Current portion of long-term debt, including $0 and $31,211 to related parties as of September 30, 2020 and December 31, 2019, respectively 421 31,670
Current portion of lease liabilities 4,584 4,182
Related party payables 357 51
Current liabilities held for sale 0 47,333
Total current liabilities 30,661 122,912
Long-term debt, net of current portion, including $25,000 to related parties as of September 30, 2020 and December 31, 2019 193,801 186,321
Deferred revenue, net of current portion, including $28,197 and $30,182 from related parties as of September 30, 2020 and December 31, 2019, respectively 30,015 48,136
Lease liabilities, net of current portion 20,323 23,849
Deferred tax liabilities 2,734 2,834
Other long-term liabilities 100 0
Total liabilities 277,634 384,052
Commitments and contingencies (Note 16)
Shareholders' equity    
Common stock, no par value, 400,000,000 shares authorized as of September 30, 2020 and December 31, 2019; 178,704,151 shares and 163,274,880 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively 0 0
Additional paid-in capital 1,838,919 1,752,048
Accumulated deficit (1,781,729) (1,652,869)
Accumulated other comprehensive income (loss) 1,362 (27,468)
Total shareholders' equity 58,552 71,711
Total liabilities and shareholders' equity $ 336,186 $ 455,763